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Reports of HIV-1 superinfection (re-infection) have demonstrated that the immune response generated against one
strain of HIV-1 does not always protect against other strains. However, studies to determine the incidence of HIV-1
superinfection have yielded conflicting results. Furthermore, few studies have attempted to identify superinfection
cases occurring more than a year after initial infection, a time when HIV-1-specific immune responses would be most
likely to have developed. We screened a cohort of high-risk Kenyan women for HIV-1 superinfection by comparing
partial gag and envelope sequences over a 5-y period beginning at primary infection. Among 36 individuals, we
detected seven cases of superinfection, including cases in which both viruses belonged to the same HIV-1 subtype,
subtype A. In five of these cases, the superinfecting strain was detected in only one of the two genome regions
examined, suggesting that recombination frequently occurs following HIV-1 superinfection. In addition, we found that
superinfection occurred throughout the course of the first infection: during acute infection in two cases, between 1–2 y
after infection in three cases, and as late as 5 y after infection in two cases. Our results indicate that superinfection
commonly occurs after the immune response against the initial infection has had time to develop and mature.
Implications from HIV-1 superinfection cases, in which natural re-exposure leads to re-infection, will need to be
considered in developing strategies for eliciting protective immunity to HIV-1.
Citation: Piantadosi A, Chohan B, Chohan V, McClelland RS, Overbaugh J (2007) Chronic HIV-1 infection frequently fails to protect against superinfection. PLoS Pathog 3(11):
e177. doi:10.1371/journal.ppat.0030177
Introduction
HIV-1 superinfection (also referred to in the literature as
re-infection) has been described in more than 20 cases [1–5],
demonstrating that natural infection with HIV-1 does not
always generate a protective immune response. Evidence of
superinfection presents a potential challenge to HIV-1
vaccine design because most of the other viruses for which
vaccines exist do elicit protective immunity in natural
infection. However, the implications of HIV-1 superinfection
for vaccine design remain controversial, in part because it is
unclear how often superinfection occurs and whether it is
restricted to times in infection when an HIV-speciﬁc immune
response has not yet developed, such as soon after the ﬁrst
infection, or has become impaired, such as during advanced
AIDS.
To date, several population-based studies have measured
the incidence of HIV-1 superinfection, with conﬂicting
results. At one extreme, two studies found that superinfection
occurred at a rate close to that of initial infection: 4% per
year among women in Kenya [1], compared to an initial
infection rate of 8% per year in the same cohort [6]; and 5%
per year among men in southern California [2], compared to
an initial infection rate of 5% per year in a comparable
cohort [7]. At the other extreme, two studies did not identify
any cases of HIV-1 superinfection despite extensive follow-up
[8,9]. Differences in study design and methodology may
account for some variability in the detection of super-
infection. It is also likely that the incidence of HIV-1
superinfection depends on the frequency of re-exposure
and potentially on characteristics of the viruses being studied.
One factor that may inﬂuence the incidence of HIV-1
superinfection is the relatedness of the virus strains. In
approximately half of the published cases of superinfection,
the initial and superinfecting viruses belonged to different
subtypes, which can differ by ;30% in the envelope gene. In
contrast to these cases of intersubtype superinfection, in
cases of intrasubtype superinfection viruses differ by ;10%
or less in env [10] and might be expected to share antigenic
properties. Intrasubtype superinfection is more difﬁcult to
detect and has primarily been documented for subtype B
viruses [2,11–16]. It is not known how often intrasubtype
superinfection occurs in regions where non-subtype B viruses
predominate, and these are the regions where HIV-1 is most
prevalent.
The rate of HIV-1 superinfection may also depend on
whether an HIV-speciﬁc immune response has been gener-
ated at the time of exposure to the second virus. It is possible
that superinfection occurs more frequently in the period
soon after the initial infection, before the development of an
HIV-1-speciﬁc immune response, although there are reports
that indicate this is not always the case [12,17,18]. The
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within the ﬁrst month after infection [19], presenting the
ﬁrst potential barrier to HIV-1 superinfection. Experimental
superinfection of macaques with HIV-2 demonstrated that
superinfection was limited to the ﬁrst month after infection
in that model [20]. However, HIV-1 superinfection in humans
has been documented to occur after the development of a
CTL response [12,16,18,21], including one case in which CTLs
recognized the superinfecting strain [12].
The other arm of the adaptive immune response to HIV-1,
neutralizing antibodies, does not arise until later in infection
but may play a stronger role in preventing superinfection.
Neutralizing antibodies have been shown to block primary
infection in an experimental animal setting [22–25]. Prelimi-
nary evidence suggests that they may also block super-
infection; Smith et al. recently found that three individuals
who became superinfected had weaker neutralizing antibody
responses to their initial infections than did control
individuals [26]. However, neutralizing antibodies generally
do not arise until 2 mo after infection, and antibodies do not
broaden to recognize heterologous strains until approxi-
mately 1 y after infection, if at all [27]. Because most of the
documented cases of superinfection occurred within the ﬁrst
year after infection [11], it is tempting to speculate that
antibodies could protect against later superinfections. How-
ever, in many studies, individuals were not followed for
longer than a year. Studies with long follow-up are needed to
determine whether later superinfections occur despite the
opportunity for the host to develop a broad immune
response.
Finally, most of the previous studies are likely to have
underestimated the incidence of superinfection because they
examined only one region of the HIV-1 genome [1,2,9] or two
neighboring regions [8]. This approach may have missed cases
of superinfection in which the initial and superinfecting
viruses recombined, a frequent event during HIV-1 repli-
cation [28]. Examining more than one region of the HIV-1
genome may provide a better estimate of the incidence of
HIV-1 superinfection.
To address these issues, we screened a prospective cohort
of Kenyan women for HIV-1 superinfection. We compared
sequences from two non-neighboring regions of the genome
(gag p17 and env V1-V5) at time points soon after the initial
infection and approximately ﬁve years later. We identiﬁed
seven cases of HIV-1 superinfection among 36 women. Three
of these cases were subtype A intrasubtype superinfections. In
the other four cases, the initial and superinfecting viruses
belonged to different subtypes in at least one of the genome
regions examined. In ﬁve out of seven cases, the super-
infecting strain was only detected in one region of the
genome (gag or env), indicating that recombination frequently
occurred following superinfection. We also deﬁned the
timing of each superinfection case, and these results indicate
that superinfection can occur as late as ﬁve years after the
initial infection.
Results
To identify potential HIV-1 superinfection cases, we
analyzed HIV-1 proviral sequences from 36 individuals at
two time points. The ﬁrst (‘‘initial’’) time point was a median
of 111 days post-infection (DPI) (range 17–338), and the
second (‘‘chronic’’) was a median of 1,901 DPI (range 1,309–
2,631, which corresponds to 3.6–7.2 y post-infection). For
each individual, we studied a median of seven gag sequences
(range 3–19) and eight env sequences (range 3–13) from the
initial time point and a median of seven gag sequences (range
5–13) and seven env sequences (range 4–12) from the chronic
time point.
In examining sequences from the initial time point,
sequences from each individual formed a monophyletic
cluster in both gag and env phylogenetic trees (unpublished
data), suggesting that all individuals were initially infected
from a single source partner (i.e., individuals were not
coinfected). The initial env sequences had a median pairwise
diversity of 2.6% (range 0%–6.4%) and a median divergence
from their most recent common ancestor (MRCA) of 1.6%
(range 0%–11.5%). The initial median gag diversity and
divergence were 0.3% (0%–1.3%) and 0.6% (0%–3.3%),
respectively. In nine individuals, the initial gag sequences
and env sequences belonged to different HIV-1 subtypes,
indicating initial infection with intersubtype recombinant
viruses. Figure 1 shows env (A) and gag (B) maximum-
likelihood phylogenetic trees containing four representative
sequences (two initial and two chronic) from each of the 36
individuals. All initial env V1–V5 sequences clustered with
subtype A reference sequences (including both sub-subtypes,
A1 and A2), which was a selection criterion for this study.
However, initial gag p17 sequences clustered with subtype C
in one individual and subtype D in three individuals and were
A1/D recombinant in two individuals and A2/D recombinant
in three individuals.
Through analysis of sequences from both the initial and
chronic time points, we identiﬁed seven potential cases of
superinfection, in which some or all of the chronic sequences
clustered separately from the initial sequences on phyloge-
netic trees of env, gag, or both. These cases are highlighted in
color on the phylogenetic trees in Figure 1. Separate
clustering was observed in both env and gag trees for one
case (Case 2), in only env for four cases (Cases 1, 3, 4, and 5),
and in only gag for two cases (Cases 6 and 7).
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Author Summary
Superinfection with HIV-1 occurs when an individual infected with
one strain of HIV-1 acquires a second strain, from a different partner.
There are more than 20 published cases of HIV-1 superinfection.
These cases have raised concerns for HIV-1 vaccine design because
they indicate that the immune response generated against natural
infection is not always sufficient to protect against later exposures
to the virus. However, it remains unclear how often HIV-1 super-
infection occurs, especially at times in infection after an immune
response would be expected. We investigated the incidence of HIV-
1 superinfection in a cohort of 36 high-risk women followed for
approximately five years after their first HIV-1 infections. We found
seven cases of HIV-1 superinfection. Five cases occurred more than a
year after the initial infection, a time when the immune response
would have had time to develop and broaden. In three cases, the
initial and superinfecting viruses were classified as the same HIV-1
genetic subtype, indicating a lack of protection against closely
related viruses. Our results suggest that natural HIV-1 infection does
not always elicit a protective immune response, an important
consideration in developing strategies for HIV-1 vaccine design and
testing.In three of these cases, the chronic sequences belonged to a
different subtype than the initial sequences, indicating
intersubtype superinfection. Speciﬁcally, as shown in Figure
1A, the initial env sequences from Case 3 are subtype A while
the chronic sequences are subtype D. The initial env
sequences from Case 4 are subtype A, while the chronic
sequences are subtype C. As shown in Figure 1B, the initial
gag sequences from Case 7 are subtype C, while the chronic
sequences cluster between subtypes A and C and are an A/C
recombinant (Figure S1). One of the remaining cases was an
inter-sub-subtype superinfection: the initial sequences from
Case 2 were sub-subtype A2 in env and D/A2 recombinant in
gag (Figure S2A), while the chronic sequences were sub-
subtype A1 in env and D/A1 in gag (Figure S2B). In the
remaining three cases (Cases 1, 5, and 6), both the initial and
chronic sequences clustered with subtype A reference
sequences, indicating intrasubtype superinfection.
Quantitative analysis of virus divergence supported super-
infection in these cases. For each individual, we calculated
divergence as the maximum genetic distance between any
chronic sequence and the MRCA of the initial sequences. To
determine what level of divergence would be expected in an
intrasubtype superinfection, we also measured the divergence
between each pair of individuals who had a subtype A virus
(including sub-subtypes A1 and A2). Figure 2 shows plots of
env (A) and gag (B) divergence within and between individuals;
the potential superinfection cases from Figure 1 are labeled.
Excluding these presumed superinfection cases, the diver-
Figure 1. Maximum-Likelihood Phylogenetic Trees of env (A) and gag (B) Sequences from 36 Individuals
Each tree contains two initial and two chronic sequences from each individual (unlabeled branches) that were selected to represent both strains in
presumed superinfection cases and were selected randomly for other cases. Reference sequences representing different subtypes from the LANL
database are also included (labeled branches). Cases that demonstrate separate clustering on either or both trees are highlighted in color. In most cases,
separate clustering is evident in only env or only gag. Sequences from each of these presumed superinfection cases are labeled with the case number
and either ‘‘initial’’ or ‘‘chronic’’ on the tree(s) that demonstrates separate clustering. Green¼Case 1, orange¼Case 2, blue¼Case 3, purple¼Case 4,
red ¼ Case 5, yellow ¼ Case 6, light blue ¼ Case 7. Bootstrap values were omitted for clarity; however, except for the superinfection cases, sequences
from each individual form a monophyletic cluster with  82% bootstrap support (most have 100% bootstrap support).
doi:10.1371/journal.ppat.0030177.g001
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Frequent HIV-1 Superinfectiongences within each individual ranged from 2.1% to 10.7% in
env (median¼4.5%) and from 1.2% to 3.9% in gag (median¼
2.3%). The between-individual divergence ranged from
10.4% to 38.2% (median ¼ 17.9%) in env and from 5.4% to
17.1% (median ¼ 10.1%) in gag. These ranges are somewhat
higher than what is typically reported [10,29,30] because we
included comparisons between sub-subtype A2 and sub-
subtype A1 sequences. Furthermore, we calculated maximum
divergence rather than average diversity in order to identify
potential superinfection cases in which just one sequence
belonged to the superinfecting strain. As shown in Figure 2,
the levels of divergence observed in the three potential
intrasubtype superinfection cases (Cases 1, 5, and 6) are in the
range that would be expected for a superinfection. Consistent
with the results of phylogenetic analysis (Figure 1), Cases 1
and 5 demonstrate high divergence in env but not gag, while
Case 6 demonstrates high divergence in gag but not env. Case
2, the inter-sub-subtype superinfection that was detected in
both env and gag shows high divergence on both plots. The
divergence in the intersubtype superinfection cases (Cases 3
and 4 in env and Case 7 in gag) is higher than in the
intrasubtype cases, as would be predicted.
For all seven potential cases of HIV-1 superinfection
identiﬁed by phylogenetic analysis, we examined samples
from intervening time points to estimate when superinfec-
tion occurred. As described below, we examined samples
using both single-copy sequencing and strain-speciﬁc PCR
(ssPCR), which allowed us to sample a greater number of
genome copies. For cases of superinfection in which the
second strain was initially detected in only env or gag, this
approach also allowed us to carefully screen the other region
at intervening time points. In one case (Case 1), we detected a
second strain in gag at an intervening time point, whereas it
was not found in our initial screen. The timing and
characterization of superinfection cases are summarized in
Table 1.
Figure 2. Maximum Divergence from the MRCA for Chronic env (A) and gag (B) Sequences
Comparisons within individuals (black circles) and between subtype A–infected individuals (gray triangles) are arbitrarily distributed along the x-axis.
Superinfection cases are labeled in both plots. For most cases, the high divergence indicative of superinfection is apparent in one region of the genome
but not the other, consistent with Figure 1.
doi:10.1371/journal.ppat.0030177.g002
Table 1. Summary and Estimated Timing of HIV-1 Superinfection Cases















Initial Chronic Initial Chronic
1 QB726 749–1,031 4.1–4.0 309 A A þ A* D D þ A* Inter
2 QB045 1,680–2,048 4.5–4.3 553 A2 A2 þ A1 D/A2 D/A2 þ D/A1 Intra
3 QB850 52–73 5.2–5.5 NA A A þ A/D A A Inter
4 QD022 1,832–1,957 4.3–5.8 788 A C A A Inter
5 QA413 714–1,007 4.9–5.0 296 A A þ A* A A Intra
6 QB685 303–1,453 2.6–4.0 628 A A A A* Intra
7 QC885 58–152 5.6–5.5 NA A A C C þ A/C Inter
aViral load (log 10 copies RNA/mL plasma) at the time points immediately before and immediately after superinfection.
bCD4 cells/uL at the time point immediately after superinfection. NA, not available.
cFor each time point, the virus subtype(s) detected are indicated. A*, a subtype A virus different from the initial subtype A virus.
dCases were classified as intersubtype if the strains belonged to different subtypes in at least one genome region (gag or env).
doi:10.1371/journal.ppat.0030177.t001
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Frequent HIV-1 SuperinfectionFigure 3. Case 1 (QB726): Intrasubtype Superinfection (Subtype A) between 749 and 1,031 DPI Detected in env and gag
(A) Plot of viral load (log RNA copies/mL plasma) versus DPI. Sequences were obtained by single-copy PCR from time points marked by circles. Arrows
indicate the initial and chronic time points used in the analysis in Figure 1, and the box indicates the first time point at which the superinfecting strain
was detected. The number of sequences of each strain at each time point is indicated in a table below the graph. ND, not done.
(B) Maximum-likelihood tree of env sequences from all time points. Sequence names from QB726 are comprised of the sample DPI and a unique
identifier. The cluster of strain A contains sequences from all time points except 1,633 and 2,876 DPI. The cluster of strain A* contains sequences from
1,031, 1,165, 1,381, and 2,002 DPI. Sequences from three other individuals (QA520, QA268, and QA750), as well as subtype reference sequences from the
LANL database, are also included. Bootstrap values greater than 70% are shown.
(C) Maximum-likelihood tree of gag sequences from all time points. Sequence names from QB726 are comprised of the sample DPI and a unique
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Frequent HIV-1 SuperinfectionCase 1 (QB726): Intrasubtype Superinfection (Subtype A)
between 749 and 1,031 DPI Detected in env and gag
For Case 1, intrasubtype superinfection was ﬁrst suggested
by separate clustering of initial and chronic envelope sequen-
ces on a phylogenetic tree (Figure 1). Env sequences from 70
DPI formed a monophyletic cluster (strain A), while some
sequences from 2,002 DPI clustered separately (strain A*). To
determine when strain A* ﬁrst appeared, we examined
multiple sequences from six intervening time points. These
time points are highlighted in Figure 3A, a plot of this
individual’s viral load throughout infection. A phylogenetic
tree of all env sequences is shown in Figure 3B. Env sequences
from 468 DPI and 749 DPI clustered with strain A sequences.
Among the sequences from 1,031 DPI, one clustered with
strain A*, suggesting that superinfection occurred between
749 and 1,031 DPI. We detected both strain A and strain A* at
1,165, 1,381, and 2,002 DPI, and we detected only strain A* in
sequences from a later sample (2,876 DPI). The number of
sequences of each strain at each time point is listed in Figure
3A.
We used ssPCR of env sequences to assess the presence or
absence of strain A* at time points before it was detected by
single-copy sequencing. This method allowed us to sample a
greater number of genome copies (50 copies per time point
versus ;6). Using primers speciﬁc for strain A*, we did not
detect the new strain in 50 genome copies from 468 or 749
DPI but did detect it at 2,876 DPI, consistent with results from
the sequence analysis (Figure 3). The 70-DPI sample was not
included in this analysis because we did not have enough
DNA available.
In our initial analysis of gag sequences from Case 1, we did
not detect a superinfecting strain at 2,002 DPI. As shown in
Figure 1, sequences from 70 and 2,002 DPI formed a
monophyletic cluster within subtype D. To determine
whether a superinfecting strain could be detected in the gag
region at intervening time points, we examined a total of 47
single-copy sequences from ﬁve samples (listed in Figure 3A).
At 1,031 DPI, we found one sequence that clustered with
subtype A sequences (A*) (Figure 3C). The subtype A strain
was not detected by single-copy sequencing at 1,165 or 1,381
DPI but was the only strain present at 2,876 DPI. Using strain-
speciﬁc gag primers, we did not detect the subtype A strain in
50 genome copies from 468 or 749 DPI but did detect it at
2,876 DPI (Figure 3E).
As summarized in Figure 3F and Table 1, these results
suggest that this individual was initially infected with an
intersubtype recombinant strain, containing subtype A in env
and subtype D in gag. Between 749 and 1,031 DPI, this
individual acquired a second strain that belonged to subtype
A, which was detected in both env and gag sequences, although
less consistently in gag.
Case 2 (QB045): Intrasubtype Superinfection (Sub-Subtype
A2–A1) between 1,680 and 2,048 DPI Detected in env and
gag
For Case 2, intrasubtype superinfection was suggested by
separate clustering of initial and chronic sequences in both
env and gag phylogenetic trees (Figure 1). Env sequences from
164 DPI formed a monophyletic cluster within sub-subtype
A2, while at 2,048 DPI, one env sequence (out of eight)
clustered with sub-subtype A1. We examined env sequences
from three available intervening time points (Figure 4A) and
found only the initial sub-subtype A2 strain in a total of 24
sequences (Figure 4B). To conﬁrm the presence of the
superinfecting strain, we also examined sequences from a
later sample, 2,247 DPI. At this time point, we found env
sequences from both the sub-subtype A2 strain (n¼6) and the
sub-subtype A1 strain (n ¼ 2) (Figure 4B).
Gag sequences from Case 2 at 164 DPI clustered most
closely with subtype A2; however, Simplot analysis indicated
that the gag sequences were a D/A2 recombinant at the initial
time point (Figure S2A). At 2,048 DPI, we detected one
subtype A1 strain and two D/A1 recombinants (Figures 1 and
S2B). To determine whether the recombinant strain was
derived from the initial subtype D/A2 strain, we separately
analyzed the 59 subtype D portion of these sequences.
Sequences from both time points clustered together on a
phylogenetic tree (unpublished data), suggesting that the D/
A1 strain present at 2,048 DPI was generated by recombina-
tion between the initial subtype D/A2 strain and the novel
subtype A1 strain. We did not detect the subtype A1 strain or
D/A1 recombinant in gag at any of the three intervening time
points (25 total sequences) or at the later time point (eight
sequences) (Figure 4C). For this individual, we did not have
enough HIV-1 DNA available to conﬁrm the timing of
superinfection using ssPCR.
As shown in Figure 4D, our results suggest that this
individual was initially infected with a subtype D/A2
recombinant (D/A2 in gag and A2 in env). Between 1,680
and 2,048 DPI, this individual was superinfected with a
subtype A1 strain, which was detected in both env and gag.
Within the gag region, we also detected a recombinant
between the initial and superinfecting strains.
Case 3 (QB850): Intersubtype Superinfection (Subtype A–
D) between 52 and 73 DPI Detected in env
For Case 3, env sequences from 45 DPI belonged to subtype
A, while at 1,768 DPI we detected both subtype A and an A/D
recombinant (Figures 1 and S3). In analysis of only the
subtype A portion (C2–V3), all sequences formed a mono-
phyletic cluster (unpublished data), suggesting that the new A/
D sequence arose by recombination between the initial
subtype A strain and a novel subtype D strain.
identifier. The cluster of strain D contains sequences from all time points except 2,876 DPI. The cluster of strain A* contains sequences from 1,031 and
2,876 DPI. Sequences from four other individuals (QC036, QA255, QD121, and QC805), as well as subtype reference sequences from the LANL database,
are also included. Bootstrap values greater than 70% are shown.
(D) Amplification of 50 HIV-1 genome copies from the indicated time points using env strain–specific primers (top panel) or env common primers
(bottom panel). For each time point, each lane contains an estimated ten HIV-1 genome copies of template input. As a control, we also amplified 10
3
copies of a cloned A sequence (two lanes) and one copy of a cloned A* sequence (four lanes).
(E) Amplification of 50 HIV-1 genome copies from the indicated time points using gag strain–specific primers (top panel) or gag common primers
(bottom panel). For each time point, each lane contains an estimated ten HIV-1 genome copies of template input. We also amplified 10
3 copies of a
cloned D sequence (two lanes) and one copy of a cloned A* sequence (four lanes).
(F) Summary of the strains detected in each genome region at the initial time point and during chronic infection (all other time points). Light gray ¼
subtype A; dark gray ¼ A*; black ¼ subtype D.
doi:10.1371/journal.ppat.0030177.g003
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Frequent HIV-1 SuperinfectionFigure 4. Case 2 (QB045): Intrasubtype Superinfection (Sub-Subtype A2–A1) between 1,680 and 2,048 DPI Detected in env and gag
The layout of this figure is similar to that of Figure 3, as described in the legend for Figure 3.
(A) Plot of viral load (log RNA copies/mL plasma) versus DPI with the number of sequences of each strain indicated.
(B) Maximum-likelihood tree of env sequences from all time points. The A2 cluster contains sequences from all time points, while the A1 cluster contains
sequences from 2,048 and 2,247 DPI.
(C) Maximum-likelihood tree of gag sequences from all time points. The cluster of strain D/A2 contains sequences from all time points. The cluster of
strains D/A1 and A1 contains sequences from 2,048 DPI.
(D) Summary of the strains detected. Light gray ¼ sub-subtype A2; dark gray ¼ sub-subtype A1; black ¼ subtype D.
doi:10.1371/journal.ppat.0030177.g004
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Frequent HIV-1 SuperinfectionIn analysis of sequences from intervening time points (Figure
5A), we detected only subtype A at 52 DPI, but both A and A/
D at 73 DPI (Figure 5B). Forty-four sequences obtained from
eight more intervening time points between 73 and 1,768 DPI
all belonged to subtype A and clustered with the 45 DPI
sequences. Using ssPCR to amplify 50 genome copies, the
second strain was not detected at 45 or 52 DPI but was
detected at 73 DPI (Figure 5).
Gag sequences from 45 and 1,768 DPI belonged to subtype
A and formed a monophyletic cluster (Figure 1). The
divergence at 1,768 DPI was unusually high: 6.1%, which is
more than 3 standard deviations higher than the average
divergence for all individuals. This high divergence could be
the result of transmission of a highly diverse virus population
from the source partner, rapid de novo evolution of the
initial strain in this individual, or superinfection by a strain
that is closely related to the initial strain. In examination of
sequences from intervening time points, we did not detect
any sequences that formed a separate cluster on a gag
phylogenetic tree (Figure 5C).
Together, these results suggest that this individual was
initially infected with a subtype A strain and was super-
infected between 52 and 73 DPI with a subtype D strain,
which recombined with the initial strain within env V1–V5
(Figure 5E). After it was ﬁrst detected at 73 DPI, the A/D
recombinant strain was not detected in a total of 44
sequences from eight time points sampled over four and a
half years, however it was detected (in three out of 12
sequences) at the last time point examined, 1,768 DPI.
Case 4 (QD022): Intersubtype Superinfection (Subtype A–
C) between 1,832 and 1,957 DPI Detected in env
For Case 4, env sequences from 51 DPI belonged to subtype
A, while those from 1,957 DPI belonged to subtype C,
suggesting intersubtype superinfection (Figure 1). Because
this individual had limited follow-up, we were only able to
study sequences from two intervening time points (Figure
6A). Sequences from 522 and 1,832 DPI belonged to subtype
A and clustered with the 51 DPI sequences (Figure 6B). To
conﬁrm presence of the subtype C strain, we also examined
sequences from a sample obtained later in infection (2,752
DPI). At this time, all env sequences belonged to subtype C
and clustered with the 1,957 DPI sequences (Figure 6B).
Results from env ssPCR supported those from single-copy
sequencing; the subtype C strain was not detected at 51, 522,
and 1,832 DPI but was detected at 1,957 DPI (Figure 6C and
unpublished data).
In the analysis of initial and chronic gag sequences, all
sequences formed a monophyletic cluster within subtype A
(Figure 1). We examined gag sequences from intervening time
points and did not observe evidence of superinfection
(unpublished data). Overall, these results suggest that this
individual was initially infected with a subtype A strain and
was superinfected with a subtype C strain between 1,832 and
1,957 DPI (Figure 6D). Because we did not detect the novel
strain in the gag region, it is likely that the two strains
recombined, and the strain that predominated contained the
initial subtype A in gag and the novel subtype C in env.
Case 5 (QA413): Intrasubtype Superinfection (Subtype A)
between 714 and 1,007 DPI Detected in env
In this case, env sequences from 45 DPI formed a mono-
phyletic cluster, while some sequences from 1,346 DPI formed
a separate cluster within subtype A, suggesting intrasubtype
superinfection (Figure 1). We examined env sequences from
six intervening time points (Figure 7A) and ﬁrst detected the
superinfecting strain (A*) at 1,007 DPI (Figure 7B). Using
ssPCR, we did not detect strain A* in env in 50 genome copies
from 57, 275, 411, 607, or 714 DPI but did detect it at 1,007
DPI (Figure 7C and unpublished data).
In examination of gag sequences, we did not identify a
novel strain in 23 total sequences from 714, 1,007, 1,146, or
1,346 DPI (unpublished data). Based on these results, it
appears that this individual was initially infected with a
subtype A strain and was superinfected with another subtype
A strain between 714 and 1,007 DPI. As in Case 4, our failure
to detect the superinfecting strain in the gag region suggests
that the strains recombined, generating a variant that
contained the initial subtype A strain in gag and the novel
subtype A strain in env (Figure 7D).
Case 6 (QB685): Intrasubtype Superinfection (Subtype A)
between 303 and 1,453 DPI Detected in gag
Intrasubtype superinfection in this case was suggested by
separate clustering of initial (86 DPI) and chronic (1,800 DPI)
gag sequences (Figure 1). Only two intervening samples were
available for estimating the timing of superinfection in this
case (Figure 8A). The superinfecting strain (A*) was detected
at 1,453 but not 303 DPI by single-copy sequencing (Figure
8B). Using ssPCR to amplify 50 genome copies, we also
detected A* at 1,453 but not 303 or 86 DPI (Figure 8C).
In the analysis of env sequences from Case 6, initial and
chronic sequences clustered together on a phylogenetic tree
(Figure 1), although the divergence at 1,800 DPI was relatively
high (8.2%). Examination of sequences from intervening time
points did not reveal the presence of a second strain. These
results suggest that this individual acquired a subtype A
intrasubtype superinfection between 303 and 1,453 DPI
(Figure 8D). Because we did not detect the second strain in
the env region, it is likely that the two strains recombined
(Figure 8D).
Case 7 (QC885): Intersubtype Superinfection (Subtype C–
A) between 58 and 152 DPI Detected in gag
Gag sequences sampled from Case 7 at 58 DPI belonged to
subtype C, while those sampled at 1,405 DPI clustered
Figure 5. Case 3 (QB850): Intersubtype Superinfection (Subtype A–D) between 52 and 73 DPI Detected in env
The layout of this figure is similar to that of Figure 3, as described in the legend for Figure 3.
(A) Plot of viral load (log RNA copies/mL plasma) versus DPI with the number of sequences of each strain indicated.
(B) Maximum-likelihood tree of env sequences from all time points. Cluster A contains sequences from all time points, while cluster A/D contains
sequences from 73 and 1,768 DPI.
(C) Maximum-likelihood tree of gag sequences from all time points, illustrating unusually high divergence.
(D) Amplification of 50 HIV-1 env genome copies from the indicated time points using strain-specific primers (top panel) and common primers (bottom
panel).
(E) Summary of the strains detected. Light gray ¼ subtype A; black ¼ subtype D.
doi:10.1371/journal.ppat.0030177.g005
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Frequent HIV-1 Superinfectionbetween subtypes A and C (Figure 1). Simplot analysis of the
chronic sequences revealed A/C recombinant sequences
(Figure S1). Phylogenetic analysis of the 39 subtype C portion
of these sequences indicated that the novel subtype C was
derived from the original subtype C (unpublished data).
To determine when the A/C strain ﬁrst appeared, we
examined sequences from ﬁve intervening time points
(Figure 9A). The A/C recombinant was detected at the earliest
available intervening time point (152 DPI) and several other
time points (Figure 9B). Using ssPCR, we did not detect the A/
C strain in 50 genome copies from the 58 DPI sample but did
detect it at 152 DPI (Figure 9C). In addition, the super-
infecting strain was not detected in analysis of env sequences
from any time point (unpublished data).
As shown in Figure 9D, these results suggest that this
individual was initially infected with a C/A recombinant (C in
gag,Ai nenv). This individual acquired a novel subtype A
strain between 58 and 152 DPI, which recombined with the
initial subtype C strain within the gag region studied and was
not detected in the env region.
Summary of Superinfection Cases
Overall, we observed seven cases of HIV-1 superinfection
among 36 individuals with 188.7 total person-years of follow-
up, corresponding to an incidence of 3.7% per person-year.
Superinfection occurred throughout the course of infection,
with the earliest between 52–73 DPI and the latest between
1,832–1,957 DPI (Table 1). In most cases, the viral load at the
time of superinfection was at the expected level for this
cohort. The median viral load at the time point before
superinfection was 4.5 log copies RNA/mL plasma (range 2.6–
5.6), compared to a median viral load set point of 4.5 log
copies RNA/mL plasma in this cohort [31]. The median log
viral load at the time point after superinfection was 5.1 log
copies RNA/mL plasma (range 4.0–5.8). Our sample size was
too small for a meaningful statistical analysis of the change in
Figure 6. Case 4 (QD022): Intersubtype Superinfection (Subtype A–C) between 1,832 and 1,957 DPI Detected in env
The layout of this figure is similar to that of Figure 3, as described in the legend for Figure 3.
(A) Plot of viral load (log RNA copies/mL plasma) versus DPI with the number of sequences of each strain indicated.
B) Maximum-likelihood tree of env sequences from all time points. Cluster A contains sequences from 51, 522, and 1,832 DPI, while cluster C contains
sequences from 1,957 and 2,752 DPI.
(C) Amplification of 50 env HIV-1 genome copies from the indicated time points using strain-specific primers (top panel) and common primers (bottom
panel).
(D) Summary of the strains detected. Light gray ¼ subtype A; black ¼ subtype C.
doi:10.1371/journal.ppat.0030177.g006
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negligible for ﬁve of the seven individuals (median 0.0 log
copies RNA/mL plasma, range: 0.2 to 0.2). For the other two
individuals (Cases 4 and 6), the viral load increased
substantially (by 1.5 log copies RNA/mL plasma) between
the time points immediately before and immediately after
superinfection (Figures 6A and 8A). CD4 counts were
available for ﬁve of the seven individuals at the time point
after superinfection and in all ﬁve cases were greater than 200
cells/uL (Table 1).
Superinfection was detected in analysis of both env and gag
sequences in only two of the seven cases, and in one of these
cases the superinfecting strain was detected in both regions
only at some time points. In the other ﬁve cases, the
superinfecting and initial strains recombined. In ﬁve cases,
both the initial and superinfecting strains persisted through-
out infection in at least one genome region, while in the
remaining two cases (Cases 4 and 6), the initial strain was not
present to our level of detection after superinfection,
suggesting that it was substantially replaced by the super-
infecting strain.
Discussion
This study represents the most in-depth population-level
assessment of the incidence and timing of HIV-1 super-
infection to date. Although the number of individuals
included in the study was relatively small, they had extensive
long-term follow-up. Importantly, because individuals were
enrolled before their ﬁrst infection and followed for
approximately ﬁve years after infection, we were able to
assess the incidence of superinfection throughout the course
of HIV-1 infection. By contrast, many of the previously
Figure 7. Case 5 (QA413): Intrasubtype Superinfection (Subtype A) between 714 and 1,007 DPI Detected in env
The layout of this figure is similar to that of Figure 3, as described in the legend for Figure 3.
(A) Plot of viral load (log RNA copies/mL plasma) versus DPI with the number of sequences of each strain indicated.
(B) Maximum-likelihood tree of env sequences from all time points. The cluster of strain A contains sequences from all time points, while the cluster of
strain A* contains sequences from 1,007, 1,146, and 1,346 DPI.
(C) Amplification of 50 env HIV-1 genome copies from the indicated time points using strain-specific primers (top panel) and common primers (bottom
panel).
(D) Summary of the strains detected. Light gray ¼ subtype A; dark gray ¼ A*.
doi:10.1371/journal.ppat.0030177.g007
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case reports [3,12,15,16,18,32,33] or in studies with short
follow-up time [2,17,21]. In addition, the design of this cohort
included frequent longitudinal sampling, and as a result, in
most cases we were able to pinpoint the timing of super-
infection to within months. These studies indicate that HIV-1
superinfection occurs both during acute infection and during
chronic infection, as late as 5 y post-infection. Five out of
seven of the superinfections we detected occurred more than
a year after infection and while CD4 counts were above 200
cells/uL (before the onset of AIDS and initiation of treat-
ment). In these cases, the immune response to natural
infection was not sufﬁcient to protect against re-infection.
We found that superinfection, even during chronic
infection, was not limited to viruses that are distantly related.
We detected three cases of subtype A intrasubtype super-
infection. To our knowledge, these are the ﬁrst documented
cases of intrasubtype superinfection with subtype A. Subtype
A is highly prevalent in Africa and is the most common
subtype in this cohort, representing ;80% of initial
infections [34]. Therefore, we expected most superinfections
to be with subtype A viruses. To have the best chance of
detecting intrasubtype superinfections in this study, we
selected individuals whose initial infection was with subtype
A viruses, based on env V1–V3 sequences [34]. However, by
examining virus sequences from a second region of the
genome (gag) during primary infection, we found that nine of
the 36 individuals (25%) were initially infected with inter-
subtype recombinant viruses. This is consistent with prior
studies that reported a high prevalence of intersubtype
recombinant viruses in Kenya [35–37]. We found that two of
the individuals initially infected with intersubtype recombi-
nant viruses acquired superinfections with subtype A viruses.
Another two individuals who were initially infected with
subtype A viruses became superinfected with subtype C or D
viruses. Thus, there were four intersubtype superinfections,
which we deﬁned as cases in which the two strains belonged
to different subtypes in at least one genome region (gag or
Figure 8. Case 6 (QB685): Intrasubtype Superinfection (Subtype A) between 303 and 1,453 DPI Detected in gag
The layout of this figure is similar to that of Figure 3, as described in the legend for Figure 3.
(A) Plot of viral load (log RNA copies/mL plasma) versus DPI with the number of sequences of each strain indicated.
(B) Maximum-likelihood tree of gag sequences from all time points. The cluster of strain A contains sequences from all time points except 1,800 DPI. The
cluster of strain A* contains sequences from 1,453 and 1,800 DPI.
(C) Amplification of 50 gag HIV-1 genome copies from the indicated time points using strain-specific primers (top panel) and common primers (bottom
panel).
(D) Summary of the strains detected. Light gray ¼ subtype A; dark gray ¼ A*.
doi:10.1371/journal.ppat.0030177.g008
PLoS Pathogens | www.plospathogens.org November 2007 | Volume 3 | Issue 11 | e177 1756
Frequent HIV-1 Superinfectionenv). Although we detected both intersubtype and intra-
subtype superinfection, we did not have sufﬁcient power to
compare their rates.
Because we screened two regions of the HIV-1 genome, we
were able to identify more cases of superinfection than we
would have detected by examining only one region. Specif-
ically, had we only examined env, we would have detected ﬁve
cases, and had we only examined gag, we would have detected
four cases. We interpret these results to indicate that
recombination frequently occurred following superinfection
(in ﬁve out of seven cases). This is concerning because it
suggests that superinfection could provide a mechanism for
HIV-1 to rapidly gain ﬁtness. For example, superinfection
followed by recombination could allow the rapid acquisition
of antiretroviral drug resistance or contribute to immune
escape. Moreover, because of the high frequency of recombi-
nation that we observed, it is likely that we missed some
superinfections that we would have detected by examining a
greater proportion of the HIV-1 genome. Speciﬁcally, we
would have missed cases in which recombination occurred
and the superinfecting strain was no longer represented in
either gag p17 or env V1-V5. Similarly, other studies that
examined a small proportion of the genome may have
underestimated the incidence of HIV-1 superinfection.
It is also possible that we missed some cases of super-
infection that occurred transiently, as seen by Yerly et al. [17].
In fact, in one case described here, we detected the super-
infecting strain at only two of 12 time points studied. We also
could have missed cases in which the superinfecting strain
was maintained at a low level. Using a binomial distribution,
we calculated that in our initial examination of ;7 sequences
per time point, we had a 79% probability of detecting a strain
present at 20% prevalence, a 52% probability of detecting a
strain present at 10% prevalence, and only a 30% probability
of detecting a strain present at 5% prevalence. Because our
initial screen could have missed a strain present at a low level,
our estimated incidence of 3.7% per person-year is likely to
be an underestimate of the true incidence of HIV-1 super-
infection.
It is important to note that, as in all studies of HIV-1
Figure 9. Case 7 (QC885): Intersubtype Superinfection (Subtype C–A) between 58 and 152 DPI Detected in gag
The layout of this figure is similar to that of Figure 3, as described in the legend for Figure 3.
(A) Plot of viral load (log RNA copies/mL plasma) versus DPI with the number of sequences of each strain indicated.
(B) Maximum-likelihood tree of gag sequences from all time points. The cluster of strain C contains sequences from all time points except 339 and 1,405
DPI. The cluster of strain A/C contains sequences from 152, 339, 635, and 1,405 DPI.
(C) Amplification of 50 gag HIV-1 genome copies from the indicated time points using strain-specific primers (top panel) and common primers (bottom
panel).
(D) Summary of the strains detected. Light gray ¼ subtype A; black ¼ subtype C.
doi:10.1371/journal.ppat.0030177.g009
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which the two strains were acquired simultaneously or nearly
simultaneously (co-infections) and one strain was maintained
in a different compartment or at a low level. However, the
results from ssPCR, in which we sampled 50 HIV-1 genomes
per time point, argue against this. We calculated that by using
ssPCR we had a .99% probability of detecting a strain
present at 10% prevalence, a 92% probability of detecting a
strain present at 5% prevalence, and a 40% probability of
detecting a strain present at 1% prevalence. It is noteworthy
that in all cases examined here, as well as three cases of
superinfection described previously [1], the results of ssPCR
and sequence analyses were absolutely concordant, and both
indicated the same timing of superinfection.
The frequency of HIV-1 superinfection that we detected,
3.7% per year, is approximately half the incidence of primary
infection in this cohort, ;8% per year [6]. It is likely that the
women in this study, who are sex workers, were exposed to
HIV-1 more frequently than women in the general popula-
tion. However, their level of exposure is lower than in other
populations where superinfection and co-infection have been
reported [21,38,39]. In the original study from which the
group examined here was derived, HIV-negative women
reported 1–2 sex partners per week and an 83% frequency of
condom use [31]. It is notable that, in the original study
cohort, the frequency of unprotected intercourse decreased
after HIV-1 infection for women who became HIV-1-infected
[40]. Therefore, although the overall incidence of super-
infection is lower than that of initial infection, the rate per
exposure may be quite similar. Because of the relatively small
sample size of this study, we were unable to determine
whether either the overall incidence or the rate per exposure
was statistically signiﬁcantly different for superinfection
versus initial infection. Large population-based studies,
controlling for behavioral and other risk factors, are needed
to determine whether there is any role of initial HIV-1
infection in preventing subsequent infections.
Our study clearly demonstrates that HIV-positive individ-
uals are at continued risk of acquiring a second HIV
infection. However, it does not provide conclusive informa-
tion on the clinical consequences of HIV-1 superinfection.
Many of the previously published studies have shown an
increase in viral load and faster disease progression in
superinfected individuals [2,3,12,15–18,21,33,39,41] and du-
ally infected individuals [13]. In two of the HIV-1 super-
infection cases described here, viral load increased
substantially between the time points before and after
superinfection. However, in the other ﬁve cases, we did not
observe a change in viral load. The fact that we observed no
change in viral load in the majority of superinfection cases
may be a consequence of our study design; we did not select
individuals with viral load change or any other speciﬁc
characteristics other than adequate follow-up. In addition, we
noticed that our ability to consistently detect both viral
strains was different for cases with and without viral load
change. Speciﬁcally, in the two cases in which viral load
changed substantially, the superinfecting strains appeared to
replace the initial strains (to our limit of detection). In the
ﬁve cases with no viral load change, both viruses persisted
after superinfection. Among the latter cases, it is unclear
whether there were some cases in which the superinfecting
strain was maintained at a lower level than the initial strain
because we could not discern what fraction of the overall
virus burden was due to each strain. Quantitative analyses of
viral RNA using primers speciﬁc for each virus will be needed
to better address and deﬁne the replication dynamics of each
virus over time.
The observed association between viral replacement and
change in viral load may suggest that virus ﬁtness plays a role
in determining the clinical consequences of superinfection.
For example, if an individual is superinfected by a highly ﬁt
virus, it may out-compete the initial virus and lead to
increased viral load. On the other hand, if both viruses are
of approximately equal ﬁtness, both might persist without
dramatically changing disease progression. Upon inspection
of previously published cases of HIV-1 superinfection,
increased viral load was associated with apparent replace-
ment of the initial strain in many cases [1,2,12,14–18,33,41].
Further studies comparing virus ﬁtness in cases of increased
viral load versus stable viral load may reveal virus character-
istics that contribute to the occurrence and outcome of HIV-
1 superinfection.
Including the cases presented here, there are now more
than 30 documented cases of HIV-1 superinfection, which
demonstrate that infection with HIV-1 does not invariably
confer protection against later exposures to the virus. Our
study illustrates that this lack of protection appears to be
largely independent of the timing of re-exposure and the
relatedness of the virus strains. If the lack of protection against
re-infection is common to all HIV-infected individuals, it calls
into question the likelihood of success of an HIV-1 vaccine
that is predicated on mimicking the immune response to
natural infection. However, HIV-1 superinfection cases differ
from a vaccine-challenge setting because individuals’ immune
responses may be impaired by the ﬁrst HIV-1 infection.
Furthermore, the fact that some HIV-infected individuals
become superinfected while others do not could be the result
of speciﬁc deﬁcits in the immune response among individuals
who become superinfected. For example, there is some
evidence that individuals who develop a weak neutralizing
antibody response to their ﬁrst infection may be more
susceptible to superinfection [26]. By contrast, in several
previously published cases, the presence of a CTL response
did not protect individuals from superinfection or abrogate
the growth of the superinfecting strain [12,16,18,21]. Clarify-
ing the roles of these and other immune factors in protection
from HIV-1 superinfection may provide insight into correlates
of immune protection against HIV-1 infection in general and
may reveal improved markers for assessing vaccine candidates.
Together with a previous study in this cohort [1], we have
identiﬁed ten cases of HIV-1 superinfection among 56
individuals. These studies demonstrate that both intersubtype
and intrasubtype superinfection occur frequently and
t h r o u g h o u tt h ec o u r s eo fH I V - 1i n f e c t i o n .T h ec a s e s
identiﬁed provide an excellent opportunity to compare the
immune responses in individuals who become superinfected
to those who do not. These studies may help to shape our
understanding of immune protection from sexual trans-
mission of HIV-1. In addition, they will provide insight into
whether the lack of immune protection indicated by HIV-1
superinfection is a universal phenomenon or a consequence
of speciﬁc host immune deﬁcits. Distinguishing between these
possibilities will help to clarify the implications of super-
infection for the success of HIV-1 vaccines.
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Study population. The individuals in this study were part of a
previously described prospective cohort of high-risk HIV-1 sero-
negative women from Mombasa, Kenya [42]. Blood samples were
obtained approximately every month and tested for infection by
HIV-1 serology. Over the period when samples were collected for this
study, 1993–2004, the average seroincidence in the cohort was 8% per
year [6]. For individuals who seroconverted, the estimated date of
infection was determined by testing stored plasma samples from
prior to seroconversion for HIV-1 RNA [31]. HIV-1-infected
individuals continued to be followed with blood samples collected
approximately every 3 mo. Beginning in 1998, absolute CD4 counts
were determined for all infected individuals [6]. All infected
individuals acquired HIV-1 through heterosexual contact [31]. The
individuals in this cohort had one to two sex partners per week; they
engaged in sex work to supplement income, but typically not as a
primary source of support [43]. None of the women reported using
antiretroviral therapy during follow-up for the present study,
although some have since started therapy due to CD4 counts ,200/
uL. Thirty-six individuals were included in this study based on the
following criteria: infection with a subtype A virus based on envelope
V1–V3 sequences [34], availability of a blood sample from within the
ﬁrst year of infection, and available samples for approximately 5 y
post-infection. Informed consent was obtained from all participants.
The study was approved by the ethical review committees of the
University of Nairobi, the University of Washington, and the Fred
Hutchinson Cancer Research Center.
Molecular analyses. HIV-1 proviral DNA sequences were obtained
from two time points for each of the 36 individuals: the ﬁrst visit after
the detection of seroconversion and a visit during chronic infection
(approximately 5 y later). For individuals identiﬁed as potential
superinfection cases, samples were also analyzed from intervening
follow-up visits. DNA was extracted from ;5 million viable frozen
PBMCs using the QIAamp DNA Blood Mini kit (Qiagen).
For each sample, the HIV-1 proviral copy number was estimated
using real-time quantitative PCR to amplify a 165-bp region of pol
[44,45]. From an estimated one copy of proviral template, separate
nested PCRs were used to amplify two regions of the HIV-1 genome:
envelope V1–V5 (;1.2 kb) and gag p17 (;700 bp). PCR primers and
conditions are described in Table S1 (env) and Table S2 (gag). For each
sample, at least 24 independent PCRs were performed. The PCR
products were treated with Exo-SAP (Amersham Biosciences) and
directly sequenced.
Phylogenetic analysis. Sequences were assembled using Sequench-
er (Gene Codes) and automatically aligned using Clustal X [46].
Alignments were manually edited using MacClade 4.01 [47], and
regions that could not be unambiguously aligned (mainly regions of
env V1/V2 and V4) were removed from analysis. We also removed
virus sequences that were identiﬁed as hypermutated, using a
modiﬁed version of the method used by Pace et al. [48].
Phylogenetic trees were constructed by two methods: neighbor-
joining using an HKY85 model in PAUP* [49] and maximum-
likelihood (ML) using a general time reversible model in GARLI 0.95
[50]. Both methods yielded comparable results, and only the ML trees
are shown. Trees were prepared for publication, including coloring
branches and removing branch names using TreeDyn [51]. For each
individual, the MRCA of the sequences from the earliest available
sample was reconstructed using maximum likelihood in GARLI.
Genetic distances were calculated using a general time reversible
model in PAUP*. Genetic diversity was deﬁned as the average
pairwise distance between sequences. Divergence was deﬁned as the
maximum pairwise distance between a sequence and the MRCA of
the same individual. For each pair of individuals, the between-
individual divergence was calculated as the maximum pairwise
distance between a sequence from one individual and the MRCA of
the other individual.
Virus subtypes were determined using the NCBI genotyping tool
[52] and by clustering on phylogenetic trees with reference sequences
from the Los Alamos National Laboratory HIV database (http://www.
hiv.lanl.gov/). Intersubtype recombinant sequences were character-
ized using Simplot [53]; sequences were compared to reference
sequences of known subtype obtained from the LANL database.
ssPCR. For each case of superinfection, primers were designed to
speciﬁcally amplify the second (superinfecting) strain. For each
region (gag and env), common primers were also designed to amplify
all strains in the superinfection cases. Primers and PCR conditions
are listed in Tables S1 (env) and S2 (gag). PCR products representing
the ﬁrst and second strains in each superinfection case were cloned
into a TOPO 2.1 vector and ampliﬁed with the common and speciﬁc
primers. In each case, the speciﬁc primers could amplify one copy of
the superinfecting strain, but not 10
3 copies of the initial strain.
Common primers could amplify all strains using one copy of
template. As expected, ampliﬁcations from an estimated single copy
of template were successful approximately 1/3–1/2 of the time. DNA
from PBMCs was ampliﬁed using a nested PCR with common primers
in the ﬁrst round and either common or strain-speciﬁc primers in the
second round.
Supporting Information
Figure S1. Simplot Analysis of gag Sequences from Case 7
A sequence from 1,405 DPI was compared to reference sequences of
known subtype from the LANL database.
Found at doi:10.1371/journal.ppat.0030177.sg001 (43 KB PDF).
Figure S2. Simplot Analysis of gag Sequences from Case 2
Sequences from 164 DPI (A) and 2,048 DPI (B) were compared to
reference sequences of known subtype from the LANL database.
Found at doi:10.1371/journal.ppat.0030177.sg002 (81 KB PDF).
Figure S3. Simplot Analysis of env Sequences from Case 3
A sequence from 1,768 DPI was compared to reference sequences of
known subtype from the LANL database.
Found at doi:10.1371/journal.ppat.0030177.sg003 (45 KB PDF).
Table S1. Envelope PCR Primers
Cycling conditions for all PCRs were: 94 835 min; 353(94 831 min,
annealing temp 3 1 min, 72 833 min); 72 838 min.
Found at doi:10.1371/journal.ppat.0030177.st001 (43 KB DOC).
Table S2. Gag PCR Primers
Cycling conditions for all PCRs were: 94 835 min; 253(94 831 min,
annealing temp 3 30 s, 72 831 min); 72 836 min.
Found at doi:10.1371/journal.ppat.0030177.st002 (41 KB DOC).
Accession Numbers
Sequences from this study available on GenBank (http//
www.ncbi.nlm.nih.gov/Genbank/) are gag sequences (EU158368-
EU158771) and env sequences (EU163983-EU164399).
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